<DOC>
	<DOCNO>NCT00221013</DOCNO>
	<brief_summary>This study seek determine increase dose continuous renal replacement therapy ( CRRT ) reduce 90-day cause mortality Intensive Care Unit ( ICU ) patient severe acute renal failure ( ARF ) .</brief_summary>
	<brief_title>Augmented Vs. Normal Renal Replacement Therapy Severe Acute Renal Failure ( ARF ) .</brief_title>
	<detailed_description>Study Title - Multicentre , Unblinded , Randomised , Controlled Trial ass effect Augmented vs. Normal Continuous Renal Replacement Therapy ( CRRT ) 90-day all-cause mortality Intensive Care Unit Patients Severe Acute Renal Failure ( ARF ) . Clinical Phase - IV Study Rationale - This study provide high quality evidence mulit-center randomise control trial comparative effect different target CRRT dose patient ARF treat Australasian intensive care set . This evidence direct relevance decision care critically ill patient admit intensive care unit Australia New Zealand . If study confirm treatment effect report Lancet study , augment dose CRRT likely become standard treatment , save 250-300 lives/year Australia 15,000 lives/year worldwide . Trial Design - The propose study compare `` augmented '' CRRT regimen deliver effluent rate 40 ml/kg/hr compare `` normal '' CRRT effluent rate 25ml/kg/hr ICU patient severe ARF . Subject Participation - 90 day Rationale Number Subjects - Assuming 90-day mortality rate 60 % control group study 1,500 patient 90 % power detect 8.5 % absolute reduction 90-day mortality 60 % control group 51.5 % intervention group ( P &lt; 0.05 ) . Approximate duration Study - 36 month Study Objective ( ) Primary - The primary study outcome death cause 90 day randomisation . Secondary - Death within intensive care unit . - Death within 28 day randomisation . - Death prior hospital discharge . - Length ICU stay . - Length hospital stay . - The need duration organ support ( inotropic/vasopressor support positive pressure ventilation ) . - CRRT-free day . - Dialysis-independent survival . Criteria Inclusion 1 . The treat clinician believe patient require CRRT acute renal failure . 2 . The clinician uncertain balance benefit risk likely confer treatment high intensity lower intensity CRRT . 3 . The treating clinician anticipate treat patient CRRT least 72 hour . 4 . Informed consent obtain 5 . The patient fulfil least ONE follow clinical criterion initiate CRRT : 1 . Oliguria ( urine output &lt; 100ml/6hr ) unresponsive fluid resuscitation measure . 2 . Hyperkalemia ( [ K+ ] &gt; 6.5 mmol/L ) . 3 . Severe acidemia ( pH &lt; 7.2 ) . 4 . Urea &gt; 25 mmol/liter . 5 . Creatinine &gt; 300 micromol/L set ARF . 6 . Clinically significant organ oedema set ARF ( eg : lung ) . Criteria Exclusion 1 . Patient age &lt; 18 year . 2 . Death imminent ( &lt; 24 hour ) . 3 . There strong likelihood study treatment would continue accordance study protocol . 4 . The patient treat CRRT dialysis previously hospital admission . 5 . The patient maintenance dialysis prior current hospitalisation . 6 . The patient 's body weight &lt; 60 kg &gt; 120kg . 7 . Any major illness , investigator 's judgment , substantially increase risk associate subject 's participation study . Approximate Number Subjects - 1500 Approximate Number Study Centres - 35 centre distribute Australia New Zealand participate study . Treatment Administration - Each participant randomise receive CRRT technical form CVVHDF either intensity 25ml/kg/hr effluent flow ( normal CRRT ) 40 ml/kg/hr effluent flow ( augmented CRRT ) . Safety Evaluation - Safety individual patient assess ongoing basis physical examination , include vital sign , outputs dialysis machine record , laboratory assessment , monitor adverse event . Overall study safety ensure Independent Data Safety Monitoring Committee , independent Trial investigator , perform ongoing review predefined safety parameter study conduct . Efficacy Evaluation - Overall survival 90 day post randomisation Statistical Analysis - The interim analysis conduct approximately 500 1000 patient complete 90 day follow , dictate Data Safety Monitoring Committee . The final analysis occur outcome data target 1500 subject available . At interim final analysis , baseline outcome variable compare use Students test , Chi square Mann-Whitney U test appropriate . Survival analysis assess use Mantel-Cox test . The final statistical analysis perform accord pre-determined statistical analysis plan ( Critical Care Resuscitation , 2009 press ) .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>1 . The treat clinician believe patient require CRRT acute renal failure . 2 . The clinician uncertain balance benefit risk likely confer treatment high intensity lower intensity CRRT . 3 . The treating clinician anticipate treat patient CRRT least 72 hour . 4 . Informed consent obtain 5 . The patient fulfil ONE follow clinical criterion initiate CRRT : Oliguria ( urine output &lt; 100ml/6hr ) unresponsive fluid resuscitation measure . Hyperkalemia ( [ K+ ] &gt; 6.5 mmol/L ) . Severe acidemia ( pH &lt; 7.2 ) . Urea &gt; 25 mmol/liter . Creatinine &gt; 300 micromol/L set ARF . Clinically significant organ oedema set ARF ( eg : lung ) . 1 . Patient age &lt; 18 year . 2 . Death imminent ( &lt; 24 hour ) . 3 . There strong likelihood study treatment would continue accordance study protocol . 4 . The patient treat CRRT dialysis previously hospital admission . 5 . The patient maintenance dialysis prior current hospitalisation . 6 . The patient 's body weight &lt; 60 kg &gt; 100kg . 7 . Any major illness , investigator 's judgment , substantially increase risk associate subject 's participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Acute Renal Failure</keyword>
	<keyword>Continuous Renal Replacement Therapy</keyword>
	<keyword>Continuous Veno-Venous Haemofiltration</keyword>
	<keyword>Continuous Veno-Venous Haemodiafiltration</keyword>
	<keyword>Renal Replacement Therapy</keyword>
</DOC>